Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer – Contract Pharma

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer  Contract Pharma

Mirum Pharmaceuticals announced the appointment of Rob Myers, MD, as the rare disease company’s new Chief Medical Officer. Explore recent issues of Contract Pharma covering key industry trends. Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry. Discover the newest partnerships and collaborations within the pharma sector. Keep track of key executive moves and promotions in the pharma and biopharma industry. Stay informed with the latest financial reports and updates in the pharma industry.

A video roundup of the week’s top industry news stories. Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world. Insights and analysis from industry experts on current pharma issues. A one-on-one video interview between our editorial teams and industry leaders. Listen to expert discussions and interviews in pharma and biopharma. Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry. Comprehensive company profiles featuring overviews, key statistics, services, and contact details. A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry. Download in-depth eBooks